New Products In Brief
This article was originally published in The Gray Sheet
S&N gets a knee up: Nearly 70% of patients receiving a total knee replacement may be eligible for the less-invasive Journey Deuce bi-compartmental knee system, Smith & Nephew says upon global launch of the first-in-class product July 9. Unlike total knee replacements, Journey Deuce replaces only the kneecap and the inner portion of the thigh and shin bone, the areas most commonly affected by osteoarthritis, while keeping the cruciate ligaments intact. The firm says it has trained roughly 200 surgeons on the system so far...
You may also be interested in...
A randomized COVID-19 study spanning the whole of the UK could help to bolster the UK’s reputation as a location for future clinical trials. It is also being seen partly as the result of the UK regulator's "decisive action" in fast-tracking trials for potential COVID-19 therapies.
Manufacturers of endoscopic equipment, biofeedback devices and thermometers were among those cited for regulatory violations in US FDA warning letters this week. A total of four device-related enforcement missives were released by the agency.
The biopharma industry has struggled to recruit patients into clinical trials that adequately reflect the diverse patient populations they hope to reach with new products. Failure to improve minority subgroup participation now will cost trial sponsors later.